vs
CORCEPT THERAPEUTICS INC（CORT）与Rapid7, Inc.（RPD）财务数据对比。点击上方公司名可切换其他公司
Rapid7, Inc.的季度营收约是CORCEPT THERAPEUTICS INC的1.1倍（$217.4M vs $202.1M），CORCEPT THERAPEUTICS INC净利率更高（12.0% vs 1.4%，领先10.6%），CORCEPT THERAPEUTICS INC同比增速更快（11.1% vs 0.5%），CORCEPT THERAPEUTICS INC自由现金流更多（$38.4M vs $36.4M），过去两年CORCEPT THERAPEUTICS INC的营收复合增速更高（17.3% vs 3.0%）
Corcept Therapeutics是一家制药企业，专注于严重代谢疾病、精神疾病及肿瘤疾病治疗药物的发现、开发与商业化。公司围绕皮质醇过量带来的不良影响展开研究，致力于开发可缓解相关症状的新型化合物，管理团队由首席执行官兼总裁、董事Joseph K. Belanoff医学博士领导。
Rapid7是全球领先的网络安全企业，提供漏洞管理、威胁检测与响应、云安全、安全分析等全系列安全解决方案，服务全球科技、医疗、金融、制造等行业的各类规模企业及公共部门客户，助力客户高效识别、应对和缓解网络安全风险。
CORT vs RPD — 直观对比
营收规模更大
RPD
是对方的1.1倍
$202.1M
营收增速更快
CORT
高出10.6%
0.5%
净利率更高
CORT
高出10.6%
1.4%
自由现金流更多
CORT
多$2.0M
$36.4M
两年增速更快
CORT
近两年复合增速
3.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $202.1M | $217.4M |
| 净利润 | $24.3M | $3.1M |
| 毛利率 | 98.7% | 68.9% |
| 营业利润率 | 2.2% | 1.0% |
| 净利率 | 12.0% | 1.4% |
| 营收同比 | 11.1% | 0.5% |
| 净利润同比 | -21.0% | 44.1% |
| 每股收益（稀释后） | $0.20 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CORTRPD
| Q4 25 | $202.1M | $217.4M | ||
| Q3 25 | $207.6M | $218.0M | ||
| Q2 25 | $194.4M | $214.2M | ||
| Q1 25 | $157.2M | $210.3M | ||
| Q4 24 | $181.9M | $216.3M | ||
| Q3 24 | $182.5M | $214.7M | ||
| Q2 24 | $163.8M | $208.0M | ||
| Q1 24 | $146.8M | $205.1M |
净利润CORTRPD
| Q4 25 | $24.3M | $3.1M | ||
| Q3 25 | $19.7M | $9.8M | ||
| Q2 25 | $35.1M | $8.3M | ||
| Q1 25 | $20.5M | $2.1M | ||
| Q4 24 | $30.7M | $2.2M | ||
| Q3 24 | $47.2M | $15.4M | ||
| Q2 24 | $35.5M | $6.5M | ||
| Q1 24 | $27.8M | $1.4M |
毛利率CORTRPD
| Q4 25 | 98.7% | 68.9% | ||
| Q3 25 | 97.8% | 70.2% | ||
| Q2 25 | 98.2% | 70.6% | ||
| Q1 25 | 98.5% | 71.7% | ||
| Q4 24 | 98.4% | 69.5% | ||
| Q3 24 | 98.4% | 70.6% | ||
| Q2 24 | 98.5% | 70.7% | ||
| Q1 24 | 98.3% | 70.3% |
营业利润率CORTRPD
| Q4 25 | 2.2% | 1.0% | ||
| Q3 25 | 4.9% | 2.7% | ||
| Q2 25 | 13.7% | 1.6% | ||
| Q1 25 | 2.2% | -0.0% | ||
| Q4 24 | 13.9% | 3.4% | ||
| Q3 24 | 25.5% | 6.0% | ||
| Q2 24 | 21.7% | 2.5% | ||
| Q1 24 | 20.1% | 4.7% |
净利率CORTRPD
| Q4 25 | 12.0% | 1.4% | ||
| Q3 25 | 9.5% | 4.5% | ||
| Q2 25 | 18.1% | 3.9% | ||
| Q1 25 | 13.1% | 1.0% | ||
| Q4 24 | 16.9% | 1.0% | ||
| Q3 24 | 25.9% | 7.2% | ||
| Q2 24 | 21.7% | 3.1% | ||
| Q1 24 | 18.9% | 0.7% |
每股收益（稀释后）CORTRPD
| Q4 25 | $0.20 | $0.05 | ||
| Q3 25 | $0.16 | $0.15 | ||
| Q2 25 | $0.29 | $0.13 | ||
| Q1 25 | $0.17 | $0.03 | ||
| Q4 24 | $0.25 | $0.08 | ||
| Q3 24 | $0.41 | $0.21 | ||
| Q2 24 | $0.32 | $0.09 | ||
| Q1 24 | $0.25 | $0.02 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $372.2M | $474.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $647.8M | $154.7M |
| 总资产 | $836.7M | $1.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CORTRPD
| Q4 25 | $372.2M | $474.7M | ||
| Q3 25 | $421.7M | $407.1M | ||
| Q2 25 | $342.2M | $511.7M | ||
| Q1 25 | $322.8M | $493.5M | ||
| Q4 24 | $383.3M | $521.7M | ||
| Q3 24 | $380.3M | $443.7M | ||
| Q2 24 | $473.2M | $442.6M | ||
| Q1 24 | $410.8M | $411.7M |
股东权益CORTRPD
| Q4 25 | $647.8M | $154.7M | ||
| Q3 25 | $631.9M | $127.2M | ||
| Q2 25 | $635.8M | $90.4M | ||
| Q1 25 | $683.3M | $52.7M | ||
| Q4 24 | $679.6M | $17.7M | ||
| Q3 24 | $638.8M | $-5.1M | ||
| Q2 24 | $596.2M | $-52.6M | ||
| Q1 24 | $547.9M | $-86.4M |
总资产CORTRPD
| Q4 25 | $836.7M | $1.7B | ||
| Q3 25 | $823.6M | $1.7B | ||
| Q2 25 | $801.7M | $1.6B | ||
| Q1 25 | $846.5M | $1.6B | ||
| Q4 24 | $840.6M | $1.7B | ||
| Q3 24 | $784.3M | $1.6B | ||
| Q2 24 | $714.6M | $1.5B | ||
| Q1 24 | $655.9M | $1.5B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $38.4M | $37.6M |
| 自由现金流经营现金流 - 资本支出 | $38.4M | $36.4M |
| 自由现金流率自由现金流/营收 | 19.0% | 16.8% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | 1.58× | 12.01× |
| 过去12个月自由现金流最近4个季度 | — | $146.2M |
8季度趋势，按日历期对齐
经营现金流CORTRPD
| Q4 25 | $38.4M | $37.6M | ||
| Q3 25 | $54.5M | $39.0M | ||
| Q2 25 | $43.9M | $47.5M | ||
| Q1 25 | $5.1M | $29.8M | ||
| Q4 24 | $59.3M | $63.8M | ||
| Q3 24 | $73.8M | $44.0M | ||
| Q2 24 | $41.2M | $32.9M | ||
| Q1 24 | $23.8M | $31.1M |
自由现金流CORTRPD
| Q4 25 | $38.4M | $36.4M | ||
| Q3 25 | — | $34.8M | ||
| Q2 25 | $43.9M | $46.6M | ||
| Q1 25 | $5.0M | $28.4M | ||
| Q4 24 | $59.2M | $62.6M | ||
| Q3 24 | $72.2M | $42.6M | ||
| Q2 24 | $40.8M | $32.6M | ||
| Q1 24 | — | $30.4M |
自由现金流率CORTRPD
| Q4 25 | 19.0% | 16.8% | ||
| Q3 25 | — | 16.0% | ||
| Q2 25 | 22.6% | 21.8% | ||
| Q1 25 | 3.2% | 13.5% | ||
| Q4 24 | 32.5% | 28.9% | ||
| Q3 24 | 39.5% | 19.9% | ||
| Q2 24 | 24.9% | 15.7% | ||
| Q1 24 | — | 14.8% |
资本支出强度CORTRPD
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 1.9% | ||
| Q2 25 | 0.0% | 0.4% | ||
| Q1 25 | 0.1% | 0.6% | ||
| Q4 24 | 0.1% | 0.5% | ||
| Q3 24 | 0.9% | 0.6% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 0.0% | 0.3% |
现金转化率CORTRPD
| Q4 25 | 1.58× | 12.01× | ||
| Q3 25 | 2.77× | 3.97× | ||
| Q2 25 | 1.25× | 5.70× | ||
| Q1 25 | 0.25× | 14.14× | ||
| Q4 24 | 1.93× | 29.36× | ||
| Q3 24 | 1.56× | 2.85× | ||
| Q2 24 | 1.16× | 5.03× | ||
| Q1 24 | 0.86× | 22.10× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CORT
暂无分部数据
RPD
| Products | $209.1M | 96% |
| Services | $8.2M | 4% |
